PAPER Sanford SA, Miller LV, Vaysburd M, Keeling S, Tuck BJ, Clark J, Neumann M, Syanda V, James LC, McEwan WA

The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology.

Alzheimers Dement. 2024 Feb;20(2):1013-1025. Epub 2023 Oct 17 PubMed: 37849026

PAPER Teipel SJ, Dyrba M, Levin F, Altenstein S, Berger M, Beyle A, Brosseron F, Buerger K, Burow L, Dobisch L, Ewers M, Fliessbach K, Frommann I, Glanz W, Goerss D, Gref D, Hansen N, Heneka MT, Incesoy EI, Janowitz D, Keles D, Kilimann I, Laske C, Lohse A, Munk MH, Perneczky R, Peters O, Preis L, Priller J, Rostamzadeh A, Roy N, Schmid M, Schneider A, Spottke A, Spruth EJ, Wiltfang J, Düzel E, Jessen F, Kleineidam L, Wagner M, DELCODE study group and the Alzheimer’s Disease Neuroimaging Initiative

Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach.

J Alzheimers Dis Rep. 2023;7(1):1055-1076. Epub 2023 Sep 26 PubMed: 37849637

PAPER Yu RC, Lai JC, Hui EK, Mukadam N, Kapur N, Stott J, Livingston G

Systematic Review and Meta-Analysis of Brief Cognitive Instruments to Evaluate Suspected Dementia in Chinese-Speaking Populations.

J Alzheimers Dis Rep. 2023;7(1):973-987. Epub 2023 Sep 1 PubMed: 37849633

PAPER Willis BA, Lo AC, Dage JL, Shcherbinin S, Chinchen L, Andersen SW, LaBell ES, Perahia DG, Hauck PM, Lowe SL

Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer's Disease: A Phase I Clinical Trial.

J Alzheimers Dis Rep. 2023;7(1):1015-1024. Epub 2023 Sep 15 PubMed: 37849628

PAPER Swerdlow RH, Jawdat O, Swint-Kruse L, Townley R

FUS G559A Mutation in a Patient with a Frontotemporal Dementia-Motor Neuron Disease Compatible Syndrome: A Case Report.

J Alzheimers Dis Rep. 2023;7(1):1121-1126. Epub 2023 Oct 9 PubMed: 37849626

PAPER Ikenuma H, Ogata A, Koyama H, Ji B, Ishii H, Yamada T, Abe J, Seki C, Nagai Y, Ichise M, Minamimoto T, Higuchi M, Zhang MR, Kato T, Ito K, Suzuki M, Kimura Y

Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.

EJNMMI Radiopharm Chem. 2023 Oct 18;8(1):31. PubMed: 37853253

PAPER Sagalajev B, Lennartz L, Vieth L, Gunawan CT, Neumaier B, Drzezga A, Visser-Vandewalle V, Endepols H, Sesia T

TgF344-AD Rat Model of Alzheimer's Disease: Spatial Disorientation and Asymmetry in Hemispheric Neurodegeneration.

J Alzheimers Dis Rep. 2023;7(1):1085-1094. Epub 2023 Sep 26 PubMed: 37849636

PAPER Franks KH, Cribb L, Bransby L, Buckley R, Yassi N, Chong TT, Lim YY, Pase MP

Exploring the Potential Association Between Self-Reported Psychological Stress and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Midlife: A Cross-Sectional Study.

J Alzheimers Dis Rep. 2023;7(1):1025-1031. Epub 2023 Sep 19 PubMed: 37849635

PAPER Elguero JE, Liu G, Tiemeyer K, Bandyadka S, Gandevia H, Duro L, Yan Z, McCall K

Defective phagocytosis leads to neurodegeneration through systemic increased innate immune signaling.

iScience. 2023 Oct 20;26(10):108052. Epub 2023 Sep 26 PubMed: 37854687

PAPER Kropf M

Ethical Aspects of Human Induced Pluripotent Stem Cells and Alzheimer's Disease: Potentials and Challenges of a Seemingly Harmless Method.

J Alzheimers Dis Rep. 2023;7(1):993-1006. Epub 2023 Sep 8 PubMed: 37849627

PAPER López-Aguirre M, Matarazzo M, Blesa J, Monje MH, Rodríguez-Rojas R, Sánchez-Ferro A, Obeso JA, Pineda-Pardo JA

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson's disease patients.

NPJ Parkinsons Dis. 2023 Oct 19;9(1):144. PubMed: 37852988

PAPER Fang M, Deibler SK, Nana AL, Vatsavayai SC, Banday S, Zhou Y, Almeida S, Weiss A, Brown RH, Seeley WW, Gao FB, Green MR

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis.

Front Neurosci. 2023;17:1251228. Epub 2023 Oct 2 PubMed: 37849894

PAPER Ceylan B, Düz E, Çakir T

Personalized Protein-Protein Interaction Networks Towards Unraveling the Molecular Mechanisms of Alzheimer's Disease.

Mol Neurobiol. 2024 Apr;61(4):2120-2135. Epub 2023 Oct 19 PubMed: 37855983

PAPER Zhou A, Britt C, Woods RL, Orchard SG, Murray AM, Shah RC, Rajan R, McNeil JJ, Chong TT, Storey E, Ryan J

Normative Data for Single-Letter Controlled Oral Word Association Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos.

J Alzheimers Dis Rep. 2023;7(1):1033-1043. Epub 2023 Sep 19 PubMed: 37849629

NurOwn™

THERAPEUTICS BrainStorm Cell Therapeutics, Inc. MSC-NTF Cells debamestrocel Neurotrophic factors-secreting Mesenchymal Stromal Cells Other Other Two open-label safety studies were conducted between 2011 and 2014, involving 36 ALS patients who received NurOwn™ as one-t